Colostrum Supplements Effect on the Physical Performance and Cognitive Function
Diabetes Mellitus, Type 2
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring Colostrum, Diabetes Mellitus, Type 2, Cognition, Physical Functional Performance
Eligibility Criteria
Inclusion Criteria: Apparently Healthy patients for control Patients diagnosed with T2DM Age between 18-70 Exclusion Criteria: Patients with T1DM Patients with a drug history of anabolic substances for more than 14 days duration. Patients with co-morbidities (e.g. CVS, renal, hepatic, and endocrine disorders) Pregnancy, lactation, or female patient willing for conception.
Sites / Locations
- Al-Zahraa Teaching HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Placebo Comparator
Active Comparator
Placebo Comparator
Active Comparator
Group 1 (Healthy Control)
Group 2 (Healthy control)
Group 3 (Diabetes Type 2)
Group 4 (Diabetes Type 2)
24 Patients receiving Placebo Capsule per oral once daily for 60 days.
26 Patients receiving Colostrum Capsule 500 mg (Colostrum® 500 mg Veg Capsules, nowfoods®, Illinois, USA), one capsule per oral once daily for 60 days.
23 Patients receiving Placebo Capsule per oral once daily for 60 days.
27 Patients Receiving Colostrum Capsule 500 mg (Colostrum® 500 mg Veg Capsules, nowfoods®, Illinois, USA), one capsule per oral once daily for 60 days.